RecruitingNot ApplicableNCT01521676
Predictive Clinical and Biological Parameters in Breast Cancer
Research of Predictive Clinical and Biological Parameters in Breast Cancer
Sponsor
Institut Paoli-Calmettes
Enrollment
750 participants
Start Date
Dec 1, 2010
Study Type
INTERVENTIONAL
Conditions
Summary
Research of predictive clinical and biological factors in breast cancer : genomic, proteomic, mutation
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- breast cancer
- age \> 18
- signed informed consent
Exclusion Criteria1
- emergency
Interventions
GENETICmolecular alteration
research of molecular alteration
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01521676
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
NCT0693085934 locations
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
NCT052915071 location